300534 Stock Overview
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells Chinese patent medicines, health food, and APIs in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 300534 from our risk checks.
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.90 |
| 52 Week High | CN¥12.36 |
| 52 Week Low | CN¥6.30 |
| Beta | 0.51 |
| 1 Month Change | -4.93% |
| 3 Month Change | -12.42% |
| 1 Year Change | -29.21% |
| 3 Year Change | 20.98% |
| 5 Year Change | 15.67% |
| Change since IPO | 40.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300534 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 4.5% | 0.8% | -0.4% |
| 1Y | -29.2% | -13.4% | -14.4% |
Return vs Industry: 300534 underperformed the CN Pharmaceuticals industry which returned -13.4% over the past year.
Return vs Market: 300534 underperformed the CN Market which returned -14.4% over the past year.
Price Volatility
| 300534 volatility | |
|---|---|
| 300534 Average Weekly Movement | 8.1% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300534 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300534's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 320 | Shuangxi Qian | www.lsrfzy.com |
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells Chinese patent medicines, health food, and APIs in China and internationally. The company offers Xuanfei Zhicough mixture, Yuanhu Zhitong dropping pills, Qiwei Wenyang capsules, Maxing cough capsule, and Astragalus Angelica capsules. Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD was founded in 2002 and is based in Lanzhou, China.
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Fundamentals Summary
| 300534 fundamental statistics | |
|---|---|
| Market cap | CN¥2.38b |
| Earnings (TTM) | CN¥61.65m |
| Revenue (TTM) | CN¥1.08b |
38.9x
P/E Ratio2.2x
P/S RatioIs 300534 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300534 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.08b |
| Cost of Revenue | CN¥386.23m |
| Gross Profit | CN¥693.82m |
| Other Expenses | CN¥632.17m |
| Earnings | CN¥61.65m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 27, 2024
| Earnings per share (EPS) | 0.20 |
| Gross Margin | 64.24% |
| Net Profit Margin | 5.71% |
| Debt/Equity Ratio | 19.8% |
How did 300534 perform over the long term?
See historical performance and comparison